Vitamin D Receptor Initiation Codon Polymorphism Influences Genetic Susceptibility to Type 1 Diabetes Mellitus in the Japanese Population
Overview
Authors
Affiliations
Background: Vitamin D has been shown to exert manifold immunomodulatory effects. Type 1 diabetes mellitus (T1DM) is regarded to be immune-mediated and vitamin D prevents the development of diabetes in the NOD mouse. We studied the association between T1DM and the initiation codon polymorphism in exon 2 of the vitamin D receptor gene in a Japanese population. We also investigated associations between the vitamin D receptor polymorphism and GAD65-antibody (Ab) positivity. We carried out polymerase chain reaction-restriction fragment length polymorphism analysis in 110 Japanese T1DM patients and 250 control subjects. GAD65 antibodies were assessed in 78 patients with T1DM.
Results: We found a significantly higher prevalence of the F allele / the FF genotype in the patients compared to the controls (P = 0.0069 and P = 0.014, respectively). Genotype and allele frequencies differed significantly between GAD65-Ab-positive patients and controls (P = 0.017 and P = 0.012, respectively), but neither between GAD65-Ab-negative patients and controls (P = 0.68 and P = 0.66, respectively) nor between GAD65-Ab-positive and -negative patients (P = 0.19 and P = 0.16, respectively).
Conclusions: Our findings suggest that the vitamin D receptor initiation codon polymorphism influences genetic susceptibility to T1DM among the Japanese. This polymorphism is also associated with GAD65-Ab-positive T1DM, although the absence of a significant difference between GAD65-Ab-negative patients and controls might be simply due to the small sample size of patients tested for GAD65 antibodies.
Thirunavukkarasu R, Chitra A, Asirvatham A, Jayalakshmi M J Clin Res Pediatr Endocrinol. 2023; 16(1):21-30.
PMID: 37559366 PMC: 10938518. DOI: 10.4274/jcrpe.galenos.2023.2022-12-7.
Ferraz R, Silva C, Cavalcante G, de Queiroz N, Felicio K, Felicio J Nutrients. 2022; 14(5).
PMID: 35267984 PMC: 8912721. DOI: 10.3390/nu14051010.
Liu S Diabetol Metab Syndr. 2021; 13(1):144.
PMID: 34903261 PMC: 8670261. DOI: 10.1186/s13098-021-00764-y.
Khdair S, Jarrar Y, Jarrar W Diabetes Metab Syndr Obes. 2021; 14:4079-4087.
PMID: 34584434 PMC: 8464324. DOI: 10.2147/DMSO.S333005.
Sattar N, Shaheen S, Hussain F, Jamil A Afr Health Sci. 2021; 21(1):8-14.
PMID: 34394275 PMC: 8356615. DOI: 10.4314/ahs.v21i1.3.